Cystic Fibrosis

Top Story

Anti-inflammatory agents may reduce severe symptoms in children with CF

Anti-inflammatory agents may reduce severe symptoms in children with CF
April 4, 2019
Guest Editorial

Keeping a safe distance: That's 6 feet for patients with cystic fibrosis

January 16, 2019
In this guest editorial, Anastassios C. Koumbourlis, MD, MPH, division chief of pulmonary and sleep medicine, director of the Cystic Fibrosis Center at Children's

Pliant Therapeutics raises $62 million for proof-of-concept fibrosis studies

July 16, 2018
Pliant Therapeutics raised $62 million in a series B financing to support proof-of-concept clinical trials in idiopathic pulmonary fibrosis, primary sclerosing…

Anthera halts development of EPI drug candidate Sollpura

March 13, 2018
Anthera Pharmaceuticals announced it will discontinue the development of Sollpura after the drug failed to meet the primary endpoint of a phase 3 trial. Sollpura…
More Headlines »
Special Issue Article

Review of Cystic Fibrosis

Pediatric Annals, April 2019, Volume 48 Issue 4
Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic…
More »
Video
Meeting News

VIDEO: Gefitinib may ‘change the paradigm’ to treat lung cancer

August 10, 2017
More »
Healio Jobs